CompletedPhase 2NCT04498169
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Studying Corneal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Aerie Pharmaceuticals
- Principal Investigator
- Michelle Senchyna, Ph.D.Aerie Pharmaceuticals Inc.
- Intervention
- Netarsudil Ophthalmic(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2021
Study locations (12)
- Orange County Ophthalmology, Garden Grove, California, United States
- Harvard Eye Associates, Laguna Hills, California, United States
- Cincinnati Eye Institute, Edgewood, Kentucky, United States
- Advance Eye Associates, South Dartmouth, Massachusetts, United States
- Chu Vision Institute, Bloomington, Minnesota, United States
- Minnesota Eye Care, Minnetonka, Minnesota, United States
- Ophthalmology Associates, St Louis, Missouri, United States
- Vance Thompson Vision, West Fargo, North Dakota, United States
- Comprehensive Eye Care, Westerville, Ohio, United States
- Vance Thompson Vision, Sioux Falls, South Dakota, United States
- Houston Eye Associates, Houston, Texas, United States
- Virginia Eye Consultants, Norfolk, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04498169 on ClinicalTrials.govOther trials for Corneal dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07217249Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsCase Western Reserve University
- RECRUITINGNANCT07373821Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)University Hospital Heidelberg
- RECRUITINGPHASE2NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyDesign Therapeutics, Inc.
- RECRUITINGNANCT06844123Microsurgical Robot-assisted Corneal TransplantCHU de Reims
- RECRUITINGNANCT06425666Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal DystrophyUniversity of Cologne
- RECRUITINGNCT06966167Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With CataractsEye & ENT Hospital of Fudan University
- RECRUITINGNCT06859411Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort StudyCentre Hospitalier Régional Metz-Thionville
- RECRUITINGPHASE3NCT05275972Descemet Endothelial Thickness Comparison Trial IIStanford University